- Home
- DCOMP vs NUWE Comparison
DCOMP vs NUWE Comparison
Compare DCOMP & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCOMP
- NUWE
- Stock Information
- Founded
- DCOMP N/A
- NUWE 1999
- Country
- DCOMP United States
- NUWE United States
- Employees
- DCOMP 887
- NUWE N/A
- Industry
- DCOMP Major Banks
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DCOMP Finance
- NUWE Health Care
- Exchange
- DCOMP Nasdaq
- NUWE Nasdaq
- Market Cap
- DCOMP N/A
- NUWE 3.9M
- IPO Year
- DCOMP N/A
- NUWE N/A
- Fundamental
- Price
- DCOMP $18.74
- NUWE $0.99
- Analyst Decision
- DCOMP
- NUWE Strong Buy
- Analyst Count
- DCOMP 0
- NUWE 1
- Target Price
- DCOMP N/A
- NUWE $17.00
- AVG Volume (30 Days)
- DCOMP N/A
- NUWE 54.7K
- Earning Date
- DCOMP N/A
- NUWE 05-13-2025
- Dividend Yield
- DCOMP N/A
- NUWE N/A
- EPS Growth
- DCOMP N/A
- NUWE N/A
- EPS
- DCOMP N/A
- NUWE N/A
- Revenue
- DCOMP N/A
- NUWE $8,740,000.00
- Revenue This Year
- DCOMP N/A
- NUWE $22.96
- Revenue Next Year
- DCOMP N/A
- NUWE $29.97
- P/E Ratio
- DCOMP N/A
- NUWE N/A
- Revenue Growth
- DCOMP N/A
- NUWE N/A
- 52 Week Low
- DCOMP N/A
- NUWE $0.75
- 52 Week High
- DCOMP N/A
- NUWE $11.55
- Technical
- Relative Strength Index (RSI)
- DCOMP 46.30
- NUWE 51.37
- Support Level
- DCOMP $18.45
- NUWE $0.89
- Resistance Level
- DCOMP $19.25
- NUWE $1.00
- Average True Range (ATR)
- DCOMP 0.48
- NUWE 0.08
- MACD
- DCOMP 0.04
- NUWE 0.01
- Stochastic Oscillator
- DCOMP 32.17
- NUWE 58.55
About DCOMP Dime Community Bancshares Inc. Fixed-Rate Non-Cumulative Perpetual Preferred Stock Series A
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.